ACOR - Acorda Therapeutics Inc. (ACOR) CEO Ron Cohen on Q4 2021 Results - Earnings Call Transcript

Acorda Therapeutics, Inc. (ACOR) Q4 2021 Earnings Conference Call March 9, 2022 16:30 ET Company Participants Tierney Saccavino - Executive Vice President, Corporate Communications Ron Cohen - Chief Executive Officer Mike Gesser - Chief Financial Officer Conference Call Participants Muzamil Saleem - H.C. Wainwright Presentation Operator Welcome to Acorda Therapeutics Fourth Quarter 2021 Financial and Business Update. [Operator Instructions] Please be advised that this call is being taped at the company’s request. I will now introduce you to our host, Tierney Saccavino, Executive Vice President, Corporate Communications at Acorda. Please go ahead. Tierney Saccavino Thank you, Tania, and good afternoon, everyone. Before we begin, let me remind you that our presentation will contain forward-looking statements. Detailed disclosures can be found in our SEC filings which are public, and we encourage you to refer filings. During today’s Q&A, we will first take calls from our analysts, and then we will take

For further details see:

Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q4 2021 Results - Earnings Call Transcript